Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia.

Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, Aprikyan AA, Bonilla MA, Dror Y, Kannourakis G, Newburger PE, Boxer LA, Dale DC.

Br J Haematol. 2008 Jan;140(2):210-3. Epub 2007 Nov 20.

2.

Game of clones: the genomic evolution of severe congenital neutropenia.

Touw IP.

Hematology Am Soc Hematol Educ Program. 2015;2015:1-7. doi: 10.1182/asheducation-2015.1.1.

PMID:
26637693
3.

Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis.

Grenda DS, Johnson SE, Mayer JR, McLemore ML, Benson KF, Horwitz M, Link DC.

Blood. 2002 Nov 1;100(9):3221-8.

4.

Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.

Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC.

Br J Haematol. 2010 Jul;150(2):196-9. doi: 10.1111/j.1365-2141.2010.08216.x. Epub 2010 Apr 29.

5.

Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.

Kalra R, Dale D, Freedman M, Bonilla MA, Weinblatt M, Ganser A, Bowman P, Abish S, Priest J, Oseas RS, Olson K, Paderanga D, Shannon K.

Blood. 1995 Dec 15;86(12):4579-86.

6.

Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.

Freedman MH, Alter BP.

Semin Hematol. 2002 Apr;39(2):128-33. Review.

PMID:
11957196
7.

Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.

Freedman MH, Bonilla MA, Fier C, Bolyard AA, Scarlata D, Boxer LA, Brown S, Cham B, Kannourakis G, Kinsey SE, Mori PG, Cottle T, Welte K, Dale DC.

Blood. 2000 Jul 15;96(2):429-36.

8.
9.

Genetic analysis and clinical picture of severe congenital neutropenia in Israel.

Lebel A, Yacobovich J, Krasnov T, Koren A, Levin C, Kaplinsky C, Ravel-Vilk S, Laor R, Attias D, Ben Barak A, Shtager D, Stein J, Kuperman A, Miskin H, Dgany O, Giri N, Alter BP, Tamary H.

Pediatr Blood Cancer. 2015 Jan;62(1):103-8. doi: 10.1002/pbc.25251. Epub 2014 Oct 4.

PMID:
25284454
10.

Severe congenital neutropenias.

Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K.

Nat Rev Dis Primers. 2017 Jun 8;3:17032. doi: 10.1038/nrdp.2017.32. Review.

PMID:
28593997
11.

Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.

Bellanné-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier-Redelsperger M, Chomienne C, Donadieu J.

Blood. 2004 Jun 1;103(11):4119-25. Epub 2004 Feb 12.

12.

[Hematological malignancies in congenital neutropenia].

Okada S, Nakamura K, Kobayashi M.

Rinsho Ketsueki. 2010 Jul;51(7):553-8. Review. Japanese. No abstract available.

PMID:
20693776
13.

Malignant myeloid transformation in congenital forms of neutropenia.

Freedman MH, Alter BP.

Isr Med Assoc J. 2002 Nov;4(11):1011-4.

14.

Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia.

Jeha S, Chan KW, Aprikyan AG, Hoots WK, Culbert S, Zietz H, Dale DC, Albitar M.

Blood. 2000 Nov 15;96(10):3647-9.

15.

Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden.

Carlsson G, Aprikyan AA, Ericson KG, Stein S, Makaryan V, Dale DC, Nordenskjöld M, Fadeel B, Palmblad J, Hentera JI.

Haematologica. 2006 May;91(5):589-95.

16.

Ela2 mutations and clinical manifestations in familial congenital neutropenia.

Shiohara M, Shigemura T, Saito S, Tanaka M, Yanagisawa R, Sakashita K, Asada H, Ishii E, Koike K, Chin M, Kobayashi M, Koike K.

J Pediatr Hematol Oncol. 2009 May;31(5):319-24. doi: 10.1097/MPH.0b013e3181984dbe.

PMID:
19415009
17.

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC; Severe Chronic Neutropenia International Registry.

Blood. 2006 Jun 15;107(12):4628-35. Epub 2006 Feb 23.

18.
19.

Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia.

Aprikyan AA, Kutyavin T, Stein S, Aprikian P, Rodger E, Liles WC, Boxer LA, Dale DC.

Exp Hematol. 2003 May;31(5):372-81. Erratum in: Exp Hematol. 2006 Dec;34(12):1771-2.

PMID:
12763135
20.

Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia.

Carlsson G, Fasth A, Berglöf E, Lagerstedt-Robinson K, Nordenskjöld M, Palmblad J, Henter JI, Fadeel B.

Br J Haematol. 2012 Aug;158(3):363-9. doi: 10.1111/j.1365-2141.2012.09171.x. Epub 2012 May 25.

PMID:
22624626

Supplemental Content

Support Center